Skip to main content
Smart Investors Daily
CB

OTC · CBDS

Cannabis Sativa, Inc.

Healthcare · Medical - Healthcare Information Services

$0.03

Up+$0.00 (+0.00%)

Updated Aug 22, 2026, 11:17 PM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
4.27M
P/E ratio
-2.17
Dividend yield
0.00%
52-week range
— – —
Volume
361.18K
Avg. volume
603.56K

Price performance

CBDS price history

1M range · 0 trading sessions · Daily adjusted prices

CBDS does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest CBDS news

The latest Smart Investors Daily articles mentioning CBDS.

CBDS research

Overview

Company profile and research snapshot.

Company profile

Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.